Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Corey

Showing results (41-50 of 222) with videos related to

Pageof 23
Sort By:
Cancers|April 30, 2021
Targeting Feedforward Loops Formed by Nuclear Receptor RORγ and Kinase PBK in mCRPC with Hyperactive AR SignalingXiong Zhang, Zenghong Huang, Junjian Wang, et al.
The Prostate|November 26, 2009
Low dose, alternating electric current inhibits growth of prostate cancerTheodore D Koreckij, Charles Hill, Larry Azure, et al.
Cancer Research|March 9, 2005
Osteoprotegerin in prostate cancer bone metastasisEva Corey, Lisha G Brown, Jeffrey A Kiefer, et al.
EMBO Molecular Medicine|January 3, 2025
PlexinD1 is a driver and a therapeutic target in advanced prostate cancerJing Wei, Jing Wang, Wen Guan, et al.
Oncotarget|September 22, 2021
Altered glucuronidation deregulates androgen dependent response profiles and signifies castration resistance in prostate cancerBrenna M Zimmer, Michelle E Howell, Linlin Ma, et al.
The Prostate|May 7, 2002
Establishment and characterization of osseous prostate cancer models: intra-tibial injection of human prostate cancer cellsEva Corey, Janna E Quinn, Franck Bladou, et al.
Cancers|December 2, 2020
Inhibition of Serum Response Factor Improves Response to Enzalutamide in Prostate CancerR William Watson, Haleema Azam, Claudia Aura, et al.
Plos One|January 20, 2021
Cabozantinib can block growth of neuroendocrine prostate cancer patient-derived xenografts by disrupting tumor vasculatureMark P Labrecque, Lisha G Brown, Ilsa M Coleman, et al.
Cancer Research|January 23, 2021
Ferroptosis Inducers Are a Novel Therapeutic Approach for Advanced Prostate CancerAli Ghoochani, En-Chi Hsu, Merve Aslan, et al.
The Prostate|June 29, 2010
Inhibition of angiopoietin-2 in LuCaP 23.1 prostate cancer tumors decreases tumor growth and viabilityColm Morrissey, Alex Dowell, Theodore D Koreckij, et al.
Pageof 23

Showing results (41-50 of 222) with videos related to

Sort By:
Pageof 23
Cancers|April 30, 2021
Targeting Feedforward Loops Formed by Nuclear Receptor RORγ and Kinase PBK in mCRPC with Hyperactive AR SignalingXiong Zhang, Zenghong Huang, Junjian Wang, et al.
The Prostate|November 26, 2009
Low dose, alternating electric current inhibits growth of prostate cancerTheodore D Koreckij, Charles Hill, Larry Azure, et al.
Cancer Research|March 9, 2005
Osteoprotegerin in prostate cancer bone metastasisEva Corey, Lisha G Brown, Jeffrey A Kiefer, et al.
EMBO Molecular Medicine|January 3, 2025
PlexinD1 is a driver and a therapeutic target in advanced prostate cancerJing Wei, Jing Wang, Wen Guan, et al.
Oncotarget|September 22, 2021
Altered glucuronidation deregulates androgen dependent response profiles and signifies castration resistance in prostate cancerBrenna M Zimmer, Michelle E Howell, Linlin Ma, et al.
The Prostate|May 7, 2002
Establishment and characterization of osseous prostate cancer models: intra-tibial injection of human prostate cancer cellsEva Corey, Janna E Quinn, Franck Bladou, et al.
Cancers|December 2, 2020
Inhibition of Serum Response Factor Improves Response to Enzalutamide in Prostate CancerR William Watson, Haleema Azam, Claudia Aura, et al.
Plos One|January 20, 2021
Cabozantinib can block growth of neuroendocrine prostate cancer patient-derived xenografts by disrupting tumor vasculatureMark P Labrecque, Lisha G Brown, Ilsa M Coleman, et al.
Cancer Research|January 23, 2021
Ferroptosis Inducers Are a Novel Therapeutic Approach for Advanced Prostate CancerAli Ghoochani, En-Chi Hsu, Merve Aslan, et al.
The Prostate|June 29, 2010
Inhibition of angiopoietin-2 in LuCaP 23.1 prostate cancer tumors decreases tumor growth and viabilityColm Morrissey, Alex Dowell, Theodore D Koreckij, et al.
Pageof 23